Houbao Liu

411 total citations
22 papers, 253 citations indexed

About

Houbao Liu is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Houbao Liu has authored 22 papers receiving a total of 253 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Houbao Liu's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). Houbao Liu is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). Houbao Liu collaborates with scholars based in China, Australia and Germany. Houbao Liu's co-authors include Yueqi Wang, Sheng Shen, Zhilong Ai, Dexiang Zhang, Tao Suo, Jiwen Wang, Bohao Zheng, Xiaolin Ni, Xiaoling Ni and Han Liu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Biochemical and Biophysical Research Communications.

In The Last Decade

Houbao Liu

20 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Houbao Liu China 11 127 90 67 66 36 22 253
Yunzhi Dang China 13 139 1.1× 78 0.9× 78 1.2× 90 1.4× 72 2.0× 33 418
Teng Hou China 13 208 1.6× 93 1.0× 50 0.7× 105 1.6× 79 2.2× 24 475
Zsolt Kovács Romania 10 93 0.7× 63 0.7× 42 0.6× 103 1.6× 47 1.3× 28 288
Qin Han China 8 114 0.9× 58 0.6× 25 0.4× 72 1.1× 50 1.4× 19 312
Zhengmao Lu China 10 151 1.2× 84 0.9× 46 0.7× 80 1.2× 65 1.8× 19 324
Baochun Wang China 11 181 1.4× 161 1.8× 27 0.4× 60 0.9× 83 2.3× 20 364
Wenjing Gong China 12 204 1.6× 173 1.9× 27 0.4× 48 0.7× 39 1.1× 36 359
Rui Wei China 13 144 1.1× 42 0.5× 21 0.3× 90 1.4× 42 1.2× 21 398
Russell Towers United States 8 85 0.7× 99 1.1× 61 0.9× 57 0.9× 26 0.7× 14 295

Countries citing papers authored by Houbao Liu

Since Specialization
Citations

This map shows the geographic impact of Houbao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Houbao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Houbao Liu more than expected).

Fields of papers citing papers by Houbao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Houbao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Houbao Liu. The network helps show where Houbao Liu may publish in the future.

Co-authorship network of co-authors of Houbao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Houbao Liu. A scholar is included among the top collaborators of Houbao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Houbao Liu. Houbao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gao, Zhihui, Wentao Sun, Tao Suo, et al.. (2024). Low expression of RACK1 is associated with metastasis and worse prognosis in cholangiocarcinoma. Heliyon. 10(6). e27366–e27366. 1 indexed citations
3.
4.
Zan, Rui, Sheng Shen, Yuanding Huang, et al.. (2023). Research hotspots and trends of biodegradable magnesium and its alloys. SHILAP Revista de lepidopterología. 4. 468–479. 25 indexed citations
5.
Fan, Kun, Jiwen Wang, Xiaojian Ni, et al.. (2023). MUC16 C terminal fragment activates YAP1 through Src signaling to promote gallbladder cancer growth. SHILAP Revista de lepidopterología. 2(4).
6.
Fan, Kun, Jiwen Wang, Sheng Shen, et al.. (2022). ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth. Medical Oncology. 39(6). 64–64. 2 indexed citations
7.
Fan, Kun, Jiwen Wang, Xiaojian Ni, et al.. (2022). Inhibition of 14-3-3ε by K50 acetylation activates YAP1 to promote cholangiocarcinoma growth. Experimental Cell Research. 421(2). 113404–113404. 1 indexed citations
8.
9.
Gao, Zhihui, Bohao Zheng, Wentao Sun, et al.. (2022). Biliverdin reductase B impairs cholangiocarcinoma cell motility by inhibiting the Notch/Snail signaling pathway. Journal of Cancer. 13(7). 2159–2170. 2 indexed citations
10.
Zheng, Bohao, Cheng Zhang, Wentao Sun, et al.. (2022). The clinical and prognostic factors for biliary neuroendocrine neoplasm: a study based on the SEER database. BMC Surgery. 22(1). 253–253. 4 indexed citations
11.
Li, Wei, Yueqi Wang, Qian Li, et al.. (2022). Toripalimab combined with gemcitabine and S-1 in the first-line treatment of advanced biliary tract cancer.. Journal of Clinical Oncology. 40(16_suppl). 4081–4081. 1 indexed citations
12.
Zheng, Bohao, Sheng Shen, Kwong‐Fai Wong, et al.. (2021). Clinical correlation of cadherin‐17 marker with advanced tumor stages and poor prognosis of cholangiocarcinoma. Journal of Surgical Oncology. 123(5). 1253–1262. 9 indexed citations
13.
Zheng, Bohao, Jiwen Wang, Kun Fan, et al.. (2021). lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC. Molecular Therapy — Oncolytics. 23. 124–137. 8 indexed citations
14.
Li, Wei, Yiyi Yu, Xiaojing Xu, et al.. (2021). Toripalimab with chemotherapy as first-line treatment for advanced biliary tract tumors: Update analytic results of an open-label phase II clinical study (JS001-ZS-BC001).. Journal of Clinical Oncology. 39(15_suppl). e16170–e16170. 11 indexed citations
15.
Shen, Sheng, Dexiang Zhang, Bohao Zheng, et al.. (2019). DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN. Bioscience Biotechnology and Biochemistry. 83(12). 2257–2264. 14 indexed citations
16.
17.
Liu, Houbao, et al.. (2019). KLF2 induces the senescence of pancreatic cancer cells by cooperating with FOXO4 to upregulate p21. Experimental Cell Research. 388(1). 111784–111784. 17 indexed citations
18.
Shen, Sheng, Yueqi Wang, Jiwen Wang, et al.. (2016). Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis and as a scaffold of DMBT1 and C-IAP1 complexes to activating PI3K-AKT pathway. Oncotarget. 7(45). 72833–72844. 52 indexed citations
19.
Ai, Zhilong, et al.. (2011). Arsenic oxide targets stem cell marker CD133/prominin-1 in gallbladder carcinoma. Cancer Letters. 310(2). 181–7. 11 indexed citations
20.
Ai, Zhilong, et al.. (2007). Arsenic trioxide-mediated growth inhibition in gallbladder carcinoma cells via down-regulation of Cyclin D1 transcription mediated by Sp1 transcription factor. Biochemical and Biophysical Research Communications. 360(3). 684–689. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunzhi Dang Breakdown of academic impact, for papers by Teng Hou Breakdown of academic impact, for papers by Zsolt Kovács Breakdown of academic impact, for papers by Qin Han Breakdown of academic impact, for papers by Zhengmao Lu Breakdown of academic impact, for papers by Baochun Wang Breakdown of academic impact, for papers by Wenjing Gong Breakdown of academic impact, for papers by Rui Wei Breakdown of academic impact, for papers by Russell Towers
Rankless by CCL
2026